Table 1 Patients characteristics
Characteristics | Number (%) |
|---|---|
Gender | |
Male | 60 (59.4%) |
Female | 41 (40.6%) |
Pathological diagnosis | |
Adenocarcinoma | 89 (88.11%) |
Squamous cell carcinoma | 12 (11.89%) |
Age | |
Mean ± SD | 58.43 ± 9.89 |
Min~max | 23.00~78.00 |
RT dose | |
Mean ± SD | 58.30 ± 7.73 |
Min~max | 34.00~70.00 |
EGFR patients | |
Positive | 42 (48.27%) |
Negative | 45 (51.73%) |
EGFR-positive patients | |
EGFR Exon 21 | 28 (66.66%) |
EGFR Exon 19 | 14 (33.34%) |
EML4-ALK patients | |
Positive | 7 (31.81%) |
Negative | 15 (68.19%) |
Treatment | |
RT | 54 (53.46 %) |
RT Plus other treatment modalities | 47 (46.54%) |